SAN has been the subject of several other reports. JPMorgan Chase & Co. restated a sell rating on shares of Sanofi SA in a report on Tuesday, October 4th. Kepler Capital Markets set a €89.00 ($98.89) price target on Sanofi SA and gave the company a buy rating in a report on Thursday, August 11th. Berenberg Bank set a €93.00 ($103.33) price target on Sanofi SA and gave the company a buy rating in a report on Thursday, September 8th. Societe Generale set a €100.00 ($111.11) price target on Sanofi SA and gave the company a buy rating in a report on Monday, August 1st. Finally, BNP Paribas set a €78.00 ($86.67) price target on Sanofi SA and gave the company a neutral rating in a report on Wednesday, September 14th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and seven have issued a buy rating to the stock. The stock currently has a consensus rating of Hold and an average target price of €86.18 ($95.75).
Shares of Sanofi SA (EPA:SAN) opened at 69.01 on Thursday. The stock has a market capitalization of €88.82 billion and a P/E ratio of 21.46. The firm’s 50-day moving average is €25.96 and its 200 day moving average is €25.76. Sanofi SA has a 12-month low of €22.81 and a 12-month high of €69.32.
Sanofi SA Company Profile
Sanofi, formerly Sanofi-Aventis, is a healthcare company engaged in the research, development, manufacture and marketing of therapeutic solutions. The Company operates through three segments: Pharmaceuticals, Human Vaccines (Vaccines) and Animal Health. The Pharmaceuticals segment consists of research, development, production and marketing of medicines, including those originating from Genzyme Corporation.
Receive News & Ratings for Sanofi SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi SA and related companies with MarketBeat.com's FREE daily email newsletter.